Protein engineering is a complex and time-consuming process, but with the help of Cradle, it becomes quick, efficient, and precise. Cradle is an advanced AI-powered platform that allows researchers and scientists to design improved variants of protein sequences with just a few clicks, eliminating the guesswork involved in traditional methods.

One of the main advantages of using Cradle is its integration of machine learning technology. By leveraging vast amounts of data, Cradle is able to generate protein sequences that have a predicted performance score. This feature not only saves time but also ensures that each sequence has a higher chance of success in the lab.

Furthermore, Cradle is designed to handle multiple properties and optimization tasks in a single round. This means that researchers can optimize various aspects of their protein, such as activity, thermostability, substrate specificity, and more, all at once. This not only saves time but also allows for a more holistic approach to protein engineering.

Cradle is trusted and used by industry leaders and biotech teams worldwide. It has been proven to accelerate both new and ongoing projects, as well as revisit challenging ones. From enzymes and vaccines to peptides and antibodies, Cradle can handle a wide range of proteins and their properties.

Using Cradle is easy and seamless. Researchers can bring in their own lab data or start from scratch with just a single starting sequence. The platform allows users to set up assays and objectives, generate sequences, and test them in the lab. Importing lab results is also a breeze, streamlining the entire protein engineering process.

Privacy and security are of utmost importance at Cradle. The platform ensures that all sequences and data are kept private and secure, and users have full ownership of their intellectual property. Only invited individuals can access the data, and it is never used to train models for other users. With bank-grade security measures in place, researchers can have peace of mind while using Cradle.

Cradle is backed by renowned investors such as Index Ventures and Kindred Capital, as well as a team of world-class advisors and angel investors. This support further validates the platform's capabilities and potential for impact in the biotech industry.

Ready to experience the power of Cradle? Join the world's leading biotech teams by requesting your early access invitation today and unlock a new level of protein engineering.